Breaking News Instant updates and real-time market news.

09:55
03/17/20
03/17
09:55
03/17/20
09:55

Cowen Inc (Notes) [7.75% Senior Notes Due 2033] trading resumes

TODAY'S FREE FLY STORIES

Recommendations
3M price target lowered to $197 from $208 at Credit Suisse » 08:37
01/27/21
01/27
08:37
01/27/21
08:37
MMM

3M

$175.97 /

+5.41 (+3.17%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MMM 3M
$175.97 /

+5.41 (+3.17%)

MMM 3M
$175.97 /

+5.41 (+3.17%)

07:05 Today JPMorgan
3M upgraded to Overweight with shares 'cheap enough' at JPMorgan
06:29 Today Citi
3M price target raised to $188 from $185 at Citi
05:18 Today JPMorgan
3M upgraded to Overweight from Neutral at JPMorgan
01/13/21 Deutsche Bank
3M named 'Catalyst Call: Buy Idea' at Deutsche Bank
MMM 3M
$175.97 /

+5.41 (+3.17%)

MMM 3M
$175.97 /

+5.41 (+3.17%)

MMM 3M
$175.97 /

+5.41 (+3.17%)

MMM 3M
$175.97 /

+5.41 (+3.17%)

Hot Stocks
Vaxart announces publication on healh care economic findings » 08:36
01/27/21
01/27
08:36
01/27/21
08:36
VXRT

Vaxart

$9.39 /

-0.67 (-6.66%)

Vaxart announced health…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VXRT Vaxart
$9.39 /

-0.67 (-6.66%)

VXRT Vaxart
$9.39 /

-0.67 (-6.66%)

11/18/20 B. Riley Securities
Vaxart price target lowered to $16 from $22 at B. Riley Securities
10/13/20 B. Riley Securities
B. Riley views Vaxart as key player in 'second wave' of Covid vaccines
09/09/20 B. Riley FBR
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
08/12/20 H.C. Wainwright
Vaxart price target raised to $17 from $7 at H.C. Wainwright
VXRT Vaxart
$9.39 /

-0.67 (-6.66%)

VXRT Vaxart
$9.39 /

-0.67 (-6.66%)

VXRT Vaxart
$9.39 /

-0.67 (-6.66%)

Initiation
Stamps.com assumed with a Buy at Maxim » 08:36
01/27/21
01/27
08:36
01/27/21
08:36
STMP

Stamps.com

$240.42 /

+2.45 (+1.03%)

Maxim analyst Allen Klee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STMP Stamps.com
$240.42 /

+2.45 (+1.03%)

STMP Stamps.com
$240.42 /

+2.45 (+1.03%)

08/07/20 Northland
Stamps.com downgraded to Market Perform from Outperform at Northland
08/07/20 Craig-Hallum
Stamps.com price target raised to $340 from $300 at Craig-Hallum
08/03/20 Craig-Hallum
Stamps.com price target raised to $300 from $230 at Craig-Hallum
05/28/20 Northland
Northland keeps Outperform on Stamps.com, sees e-commerce volume to persist
STMP Stamps.com
$240.42 /

+2.45 (+1.03%)

STMP Stamps.com
$240.42 /

+2.45 (+1.03%)

Hot Stocks
VF Corp. on track to return to growth in Q4 » 08:36
01/27/21
01/27
08:36
01/27/21
08:36
VFC

VF Corp.

$85.18 /

+0.35 (+0.41%)

Comments taken from Q3…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VFC VF Corp.
$85.18 /

+0.35 (+0.41%)

VFC VF Corp.
$85.18 /

+0.35 (+0.41%)

01/25/21 Cowen
VF Corp. price target raised to $99 from $91 at Cowen
01/25/21 Pivotal Research
VF Corp. price target raised to $86 from $76 at Pivotal Research
01/22/21 Williams Capital
VF Corp. initiated with a Buy at Williams Trading
01/21/21 Deutsche Bank
VF Corp. upgraded to Buy from Hold at Deutsche Bank
VFC VF Corp.
$85.18 /

+0.35 (+0.41%)

VFC VF Corp.
$85.18 /

+0.35 (+0.41%)

VFC VF Corp.
$85.18 /

+0.35 (+0.41%)

VFC VF Corp.
$85.18 /

+0.35 (+0.41%)

Earnings
Progressive reports Q4 EPS $2.85, consensus $1.66 » 08:36
01/27/21
01/27
08:36
01/27/21
08:36
PGR

Progressive

$91.63 /

-0.91 (-0.98%)

Reports net premiums…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PGR Progressive
$91.63 /

-0.91 (-0.98%)

01/13/21 Gordon Haskett
Allstate lowering auto rates by 5% in several states, says Gordon Haskett
01/08/21 Goldman Sachs
Progressive downgraded to Sell from Neutral at Goldman Sachs
01/07/21 B. Riley Securities
Progressive price target raised to $96 from $88 at B. Riley Securities
01/04/21 Wells Fargo
Progressive downgraded to Underweight from Equal Weight at Wells Fargo
PGR Progressive
$91.63 /

-0.91 (-0.98%)

PGR Progressive
$91.63 /

-0.91 (-0.98%)

PGR Progressive
$91.63 /

-0.91 (-0.98%)

Hot Stocks
Canadian Pacific launches five-for-one share split, new share repurchase program » 08:36
01/27/21
01/27
08:36
01/27/21
08:36
CP

Canadian Pacific

$342.17 /

-2.4 (-0.70%)

Canadian Pacific will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CP Canadian Pacific
$342.17 /

-2.4 (-0.70%)

CP Canadian Pacific
$342.17 /

-2.4 (-0.70%)

01/26/21 Raymond James
Canadian Pacific upgraded at Raymond James on improved traffic outlook
01/26/21 Raymond James
Canadian Pacific upgraded to Outperform from Market Perform at Raymond James
01/21/21 Scotiabank
Canadian National, Canadian Pacific cut at Scotiabank on valuation (yesterday)
01/20/21 Scotiabank
Canadian Pacific downgraded to Sector Perform from Outperform at Scotiabank
CP Canadian Pacific
$342.17 /

-2.4 (-0.70%)

Recommendations
Texas Instruments price target raised to $200 from $170 at Credit Suisse » 08:35
01/27/21
01/27
08:35
01/27/21
08:35
TXN

Texas Instruments

$171.48 /

-1.43 (-0.83%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TXN Texas Instruments
$171.48 /

-1.43 (-0.83%)

TXN Texas Instruments
$171.48 /

-1.43 (-0.83%)

07:59 Today Jefferies
Texas Instruments price target raised to $206 from $185 at Jefferies
07:27 Today RBC Capital
Texas Instruments price target raised to $180 from $155 at RBC Capital
06:54 Today Deutsche Bank
Texas Instruments price target raised to $170 from $150 at Deutsche Bank
06:43 Today Mizuho
Texas Instruments price target raised to $175 from $162 at Mizuho
TXN Texas Instruments
$171.48 /

-1.43 (-0.83%)

TXN Texas Instruments
$171.48 /

-1.43 (-0.83%)

TXN Texas Instruments
$171.48 /

-1.43 (-0.83%)

TXN Texas Instruments
$171.48 /

-1.43 (-0.83%)

Recommendations
Allstate unit sale transaction 'a clear positive,' says Evercore ISI » 08:35
01/27/21
01/27
08:35
01/27/21
08:35
ALL

Allstate

$109.54 /

-1.4 (-1.26%)

, BX

Blackstone

$65.07 /

+0.035 (+0.05%)

After Allstate (ALL)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALL Allstate
$109.54 /

-1.4 (-1.26%)

BX Blackstone
$65.07 /

+0.035 (+0.05%)

ALL Allstate
$109.54 /

-1.4 (-1.26%)

01/13/21 Gordon Haskett
Allstate lowering auto rates by 5% in several states, says Gordon Haskett
11/17/20 Barclays
Allstate initiated with an Overweight at Barclays
09/22/20 Keefe Bruyette
Allstate upgraded to Outperform from Market Perform at Keefe Bruyette
07/22/20 Citi
Citi opens 'Positive Catalyst Watch' on Allstate shares
BX Blackstone
$65.07 /

+0.035 (+0.05%)

01/14/21
Fly Intel: Top five analyst initiations
01/14/21 Piper Sandler
Blackstone initiated with an Overweight at Piper Sandler
10/29/20 Oppenheimer
Blackstone upgraded to Outperform at Oppenheimer
10/29/20 Oppenheimer
Blackstone upgraded to Outperform from Perform at Oppenheimer
ALL Allstate
$109.54 /

-1.4 (-1.26%)

BX Blackstone
$65.07 /

+0.035 (+0.05%)

BX Blackstone
$65.07 /

+0.035 (+0.05%)

ALL Allstate
$109.54 /

-1.4 (-1.26%)

BX Blackstone
$65.07 /

+0.035 (+0.05%)

BX Blackstone
$65.07 /

+0.035 (+0.05%)

Hot Stocks
Kaleyra and WebEngage announce new strategic partnership » 08:34
01/27/21
01/27
08:34
01/27/21
08:34
KLR

Kaleyra

$13.27 /

-0.5 (-3.63%)

Kaleyra announced a new…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KLR Kaleyra
$13.27 /

-0.5 (-3.63%)

KLR Kaleyra
$13.27 /

-0.5 (-3.63%)

01/06/21 Northland
Kaleyra named a top pick for 2021 at Northland
10/02/20 Northland
Twilio comments positive for Kaleyra, LivePerson and Vonage, says Northland
07/28/20 National Securities
Kaleyra initiated with a Buy at National Securities
06/29/20 Oppenheimer
Kaleyra initiated with an Outperform at Oppenheimer
  • 25
    Jun
KLR Kaleyra
$13.27 /

-0.5 (-3.63%)

Hot Stocks
United Airlines expands COVID-19 testing, pre-clearance for Hawaii travel » 08:34
01/27/21
01/27
08:34
01/27/21
08:34
UAL

United Airlines

$41.25 /

+0.87 (+2.15%)

Beginning February 1,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UAL United Airlines
$41.25 /

+0.87 (+2.15%)

UAL United Airlines
$41.25 /

+0.87 (+2.15%)

01/14/21 Susquehanna
United Airlines price target raised to $40 from $38 at Susquehanna
01/11/21 Cowen
United Airlines upgraded to Outperform from Market Perform at Cowen
01/08/21
Fly Intel: Top five analyst downgrades
01/08/21 BofA
United Airlines downgraded to Underperform from Neutral at BofA
UAL United Airlines
$41.25 /

+0.87 (+2.15%)

  • 22
    Apr
UAL United Airlines
$41.25 /

+0.87 (+2.15%)

UAL United Airlines
$41.25 /

+0.87 (+2.15%)

UAL United Airlines
$41.25 /

+0.87 (+2.15%)

Hot Stocks
KemPharm announces FDA approval of IND for KP879 » 08:34
01/27/21
01/27
08:34
01/27/21
08:34
KMPH

KemPharm

$6.41 /

-1.09 (-14.53%)

KemPharm announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KMPH KemPharm
$6.41 /

-1.09 (-14.53%)

KMPH KemPharm
$6.41 /

-1.09 (-14.53%)

01/25/21 Roth Capital
KemPharm initiated with a Buy at Roth Capital
05/20/20 H.C. Wainwright
KemPharm price target lowered to $1.50 from $2.50 at H.C. Wainwright
KMPH KemPharm
$6.41 /

-1.09 (-14.53%)

Recommendations
D.R. Horton price target raised to $100 from $88 at Credit Suisse » 08:34
01/27/21
01/27
08:34
01/27/21
08:34
DHI

D.R. Horton

$77.73 /

-1.32 (-1.67%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DHI D.R. Horton
$77.73 /

-1.32 (-1.67%)

DHI D.R. Horton
$77.73 /

-1.32 (-1.67%)

01/21/21 Janney Montgomery Scott
Meritage Homes initiated with a Neutral at Janney Montgomery Scott
01/21/21 Janney Montgomery Scott
D.R. Horton initiated with a Neutral at Janney Montgomery Scott
01/08/21 RBC Capital
D.R. Horton upgraded to Outperform from Sector Perform at RBC Capital
01/08/21 RBC Capital
D.R. Horton upgraded to Outperform from Sector Perform at RBC Capital
DHI D.R. Horton
$77.73 /

-1.32 (-1.67%)

DHI D.R. Horton
$77.73 /

-1.32 (-1.67%)

DHI D.R. Horton
$77.73 /

-1.32 (-1.67%)

DHI D.R. Horton
$77.73 /

-1.32 (-1.67%)

Hot Stocks
Microbot Medical completes discussions with FDA for Self-Cleaning Shunt » 08:33
01/27/21
01/27
08:33
01/27/21
08:33
MBOT

Microbot Medical

$9.08 /

-0.02 (-0.22%)

Microbot Medical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MBOT Microbot Medical
$9.08 /

-0.02 (-0.22%)

MBOT Microbot Medical
$9.08 /

-0.02 (-0.22%)

08/18/20 H.C. Wainwright
Microbot Medical price target raised to $20 from $19 at H.C. Wainwright
05/01/20 H.C. Wainwright
Microbot Medical price target lowered to $19 from $26 at H.C. Wainwright
MBOT Microbot Medical
$9.08 /

-0.02 (-0.22%)

Recommendations
American Express price target lowered to $115 from $120 at Credit Suisse » 08:33
01/27/21
01/27
08:33
01/27/21
08:33
AXP

American Express

$116.14 /

-5.05 (-4.17%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXP American Express
$116.14 /

-5.05 (-4.17%)

AXP American Express
$116.14 /

-5.05 (-4.17%)

08:19 Today Oppenheimer
American Express price target lowered to $128 from $136 at Oppenheimer
01/19/21
Fly Intel: Top five analyst upgrades
01/19/21 JPMorgan
American Express upgraded to Overweight from Underweight at JPMorgan
01/12/21 Susquehanna
American Express price target raised to $124 from $110 at Susquehanna
AXP American Express
$116.14 /

-5.05 (-4.17%)

AXP American Express
$116.14 /

-5.05 (-4.17%)

AXP American Express
$116.14 /

-5.05 (-4.17%)

AXP American Express
$116.14 /

-5.05 (-4.17%)

Hot Stocks
Sanofi's priority is to continue to develop two Covid vaccine candidates » 08:32
01/27/21
01/27
08:32
01/27/21
08:32
SNY

Sanofi

$49.15 /

-0.45 (-0.91%)

, GSK

GlaxoSmithKline

$39.24 /

+0.33 (+0.85%)

, TBIO

Translate Bio

$23.13 /

-1.5 (-6.09%)

Sanofi (SNY) is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$49.15 /

-0.45 (-0.91%)

GSK GlaxoSmithKline
$39.24 /

+0.33 (+0.85%)

TBIO Translate Bio
$23.13 /

-1.5 (-6.09%)

SNY Sanofi
$49.15 /

-0.45 (-0.91%)

01/19/21 UBS
Sanofi price target lowered to EUR 99 from EUR 100 at UBS
01/15/21 Deutsche Bank
Sanofi initiated with a Sell at Deutsche Bank
01/08/21 Morgan Stanley
Sanofi price target raised to EUR 105 from EUR 101 at Morgan Stanley
01/08/21 Morgan Stanley
Roche downgraded to Equal Weight from Overweight at Morgan Stanley
GSK GlaxoSmithKline
$39.24 /

+0.33 (+0.85%)

01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
01/20/21 UBS
GlaxoSmithKline price target raised to 1,450 GBp from 1,440 GBp at UBS
01/20/21
Fly Intel: Top five analyst downgrades
01/20/21 Credit Suisse
GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse
TBIO Translate Bio
$23.13 /

-1.5 (-6.09%)

12/22/20 Roth Capital
Translate Bio price target raised to $37 from $30 at Roth Capital
10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
07/07/20 H.C. Wainwright
Translate Bio price target raised to $32 from $18 at H.C. Wainwright
07/06/20
Fly Intel: Top five analyst initiations
SNY Sanofi
$49.15 /

-0.45 (-0.91%)

GSK GlaxoSmithKline
$39.24 /

+0.33 (+0.85%)

  • 26
    Jun
SNY Sanofi
$49.15 /

-0.45 (-0.91%)

GSK GlaxoSmithKline
$39.24 /

+0.33 (+0.85%)

TBIO Translate Bio
$23.13 /

-1.5 (-6.09%)

SNY Sanofi
$49.15 /

-0.45 (-0.91%)

GSK GlaxoSmithKline
$39.24 /

+0.33 (+0.85%)

GSK GlaxoSmithKline
$39.24 /

+0.33 (+0.85%)

Hot Stocks
Abercrombie & Fitch appoints Holly May as Chief Human Resources Officer » 08:32
01/27/21
01/27
08:32
01/27/21
08:32
ANF

Abercrombie & Fitch

$24.39 /

-0.04 (-0.16%)

Abercrombie & Fitch…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANF Abercrombie & Fitch
$24.39 /

-0.04 (-0.16%)

ANF Abercrombie & Fitch
$24.39 /

-0.04 (-0.16%)

01/14/21 JPMorgan
Abercrombie & Fitch price target raised to $26 from $24 at JPMorgan
12/30/20 B. Riley Securities
B. Riley checks show holiday outperformance for four retailers
12/01/20 Morgan Stanley
Abercrombie & Fitch price target raised to $14 from $10 at Morgan Stanley
11/25/20 Baird
Abercrombie & Fitch price target raised to $24 from $14 at Baird
ANF Abercrombie & Fitch
$24.39 /

-0.04 (-0.16%)

ANF Abercrombie & Fitch
$24.39 /

-0.04 (-0.16%)

ANF Abercrombie & Fitch
$24.39 /

-0.04 (-0.16%)

Hot Stocks
Cellectar Biosciences receives orphan drug designation for CLR 131 » 08:31
01/27/21
01/27
08:31
01/27/21
08:31
CLRB

Cellectar Biosciences

$1.86 /

-0.04 (-2.11%)

Cellectar Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLRB Cellectar Biosciences
$1.86 /

-0.04 (-2.11%)

CLRB Cellectar Biosciences
$1.86 /

-0.04 (-2.11%)

07/01/20 Oppenheimer
Oppenheimer bullish on Cellectar Biosciences, initiates with an Outperform
07/01/20 Oppenheimer
Cellectar Biosciences initiated with an Outperform at Oppenheimer
06/23/20
Fly Intel: Top five analyst initiations
06/23/20 Maxim
Cellectar Biosciences initiated with a Buy at Maxim
CLRB Cellectar Biosciences
$1.86 /

-0.04 (-2.11%)

  • 23
    Dec
Recommendations
Lockheed Martin price target lowered to $334 from $351 at Credit Suisse » 08:31
01/27/21
01/27
08:31
01/27/21
08:31
LMT

Lockheed Martin

$330.69 /

-13.195 (-3.84%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LMT Lockheed Martin
$330.69 /

-13.195 (-3.84%)

LMT Lockheed Martin
$330.69 /

-13.195 (-3.84%)

01/07/21 Baird
Lockheed Martin downgraded to Neutral from Outperform at Baird
01/07/21 Jefferies
Jefferies downgrades Aerojet Rocketdyne to Hold, sees higher bid as unlikely
12/22/20 Credit Suisse
Lockheed Martin price target raised to $409 from $400 at Credit Suisse
12/22/20 Truist
Aerojet Rocketdyne downgraded to Hold from Buy at Truist
LMT Lockheed Martin
$330.69 /

-13.195 (-3.84%)

LMT Lockheed Martin
$330.69 /

-13.195 (-3.84%)

LMT Lockheed Martin
$330.69 /

-13.195 (-3.84%)

Hot Stocks
Sanofi to provide support to BioNTech in manufacturing Covid vaccine » 08:31
01/27/21
01/27
08:31
01/27/21
08:31
SNY

Sanofi

$49.15 /

-0.45 (-0.91%)

, BNTX

BioNTech

$106.18 /

-4.355 (-3.94%)

, PFE

Pfizer

$37.31 /

+0.025 (+0.07%)

Sanofi (SNY) and BioNTech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$49.15 /

-0.45 (-0.91%)

BNTX BioNTech
$106.18 /

-4.355 (-3.94%)

PFE Pfizer
$37.31 /

+0.025 (+0.07%)

SNY Sanofi
$49.15 /

-0.45 (-0.91%)

01/19/21 UBS
Sanofi price target lowered to EUR 99 from EUR 100 at UBS
01/15/21 Deutsche Bank
Sanofi initiated with a Sell at Deutsche Bank
01/08/21 Morgan Stanley
Sanofi price target raised to EUR 105 from EUR 101 at Morgan Stanley
01/08/21 Morgan Stanley
Roche downgraded to Equal Weight from Overweight at Morgan Stanley
BNTX BioNTech
$106.18 /

-4.355 (-3.94%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
12/29/20 Citi
Arcturus selloff brings 'very good' buying opportunity, says Citi
12/22/20 Roth Capital
Translate Bio price target raised to $37 from $30 at Roth Capital
12/15/20 Jefferies
Jefferies starts Maravai at Buy, says 'more than just a COVID vaccine play'
PFE Pfizer
$37.31 /

+0.025 (+0.07%)

01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
01/14/21 Oppenheimer
Essa Pharma price target raised to $20 from $9 at Oppenheimer
01/05/21 Argus
Viatris initiated with a Hold at Argus
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
SNY Sanofi
$49.15 /

-0.45 (-0.91%)

BNTX BioNTech
$106.18 /

-4.355 (-3.94%)

PFE Pfizer
$37.31 /

+0.025 (+0.07%)

  • 23
    Jul
  • 06
    Feb
SNY Sanofi
$49.15 /

-0.45 (-0.91%)

BNTX BioNTech
$106.18 /

-4.355 (-3.94%)

PFE Pfizer
$37.31 /

+0.025 (+0.07%)

SNY Sanofi
$49.15 /

-0.45 (-0.91%)

BNTX BioNTech
$106.18 /

-4.355 (-3.94%)

PFE Pfizer
$37.31 /

+0.025 (+0.07%)

BNTX BioNTech
$106.18 /

-4.355 (-3.94%)

PFE Pfizer
$37.31 /

+0.025 (+0.07%)

Hot Stocks
Veritas Capital to acquire Perspecta in all-cash transaction valued at $7.1B » 08:30
01/27/21
01/27
08:30
01/27/21
08:30
PRSP

Perspecta

$26.23 /

-0.3 (-1.13%)

Perspecta announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRSP Perspecta
$26.23 /

-0.3 (-1.13%)

PRSP Perspecta
$26.23 /

-0.3 (-1.13%)

06/12/20 William Blair
William Blair sees near-term takeover of Perspecta as unlikely despite Jana news
04/02/20 Wells Fargo
Perspecta price target lowered to $18.50 from $26 at Wells Fargo
03/30/20 William Blair
Perspecta initiated with a Market Perform at William Blair
03/25/20 Wells Fargo
Good news for government contractors in COVID -19 bill, says Wells Fargo
PRSP Perspecta
$26.23 /

-0.3 (-1.13%)

PRSP Perspecta
$26.23 /

-0.3 (-1.13%)

Options
Two new option listings and one option delisting on January 27th » 08:30
01/27/21
01/27
08:30
01/27/21
08:30
JAGX

Jaguar Health

$3.27 /

-0.06 (-1.80%)

, EIDX

acquired by BBIO

$122.42 /

+ (+0.00%)

New option listings for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JAGX Jaguar Health
$3.27 /

-0.06 (-1.80%)

EIDX acquired by BBIO
$122.42 /

+ (+0.00%)

JAGX Jaguar Health
$3.27 /

-0.06 (-1.80%)

EIDX acquired by BBIO
$122.42 /

+ (+0.00%)

12/30/20 Citi
Eidos Therapeutics price target raised to $129 from $73.26 at Citi
11/18/20 BTIG
Eidos Therapeutics downgraded to Neutral from Buy at BTIG
10/12/20 H.C. Wainwright
BridgeBio price target raised to $53 from $50 at H.C. Wainwright
10/07/20
Fly Intel: Top five analyst downgrades
EIDX acquired by BBIO
$122.42 /

+ (+0.00%)

EIDX acquired by BBIO
$122.42 /

+ (+0.00%)

EIDX acquired by BBIO
$122.42 /

+ (+0.00%)

Recommendations
Johnson & Johnson price target raised to $193 from $168 at Credit Suisse » 08:29
01/27/21
01/27
08:29
01/27/21
08:29
JNJ

Johnson & Johnson

$170.48 /

+4.47 (+2.69%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$170.48 /

+4.47 (+2.69%)

JNJ Johnson & Johnson
$170.48 /

+4.47 (+2.69%)

07:59 Today Cantor Fitzgerald
Johnson & Johnson price target raised to $200 from $180 at Cantor Fitzgerald
07:51 Today Wells Fargo
Johnson & Johnson price target raised to $190 from $175 at Wells Fargo
07:44 Today Raymond James
Johnson & Johnson price target raised to $183 from $158 at Raymond James
07:42 Today Cowen
Johnson & Johnson price target raised to $195 from $170 at Cowen
JNJ Johnson & Johnson
$170.48 /

+4.47 (+2.69%)

JNJ Johnson & Johnson
$170.48 /

+4.47 (+2.69%)

JNJ Johnson & Johnson
$170.48 /

+4.47 (+2.69%)

JNJ Johnson & Johnson
$170.48 /

+4.47 (+2.69%)

Upgrade
Prologis upgraded to Outperform following 'strong' Q4 at Evercore ISI » 08:29
01/27/21
01/27
08:29
01/27/21
08:29
PLD

Prologis

$106.11 /

+3.1 (+3.01%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLD Prologis
$106.11 /

+3.1 (+3.01%)

PLD Prologis
$106.11 /

+3.1 (+3.01%)

05:51 Today Evercore ISI
Prologis upgraded to Outperform from In Line at Evercore ISI
01/13/21 Jefferies
First Industrial Realty upgraded to Buy with $49 price target at Jefferies
11/30/20 BTIG
Prologis price target raised to $117 from $100 at BTIG
11/23/20 KeyBanc
Prologis downgraded to Sector Weight at KeyBanc
PLD Prologis
$106.11 /

+3.1 (+3.01%)

Hot Stocks
Veritas Capital to acquire Perspecta in all-cash transaction valued at $7.1B  08:28
01/27/21
01/27
08:28
01/27/21
08:28
PRSP

Perspecta

$26.23 /

-0.3 (-1.13%)

 
ShowHide Related Items >><<
PRSP Perspecta
$26.23 /

-0.3 (-1.13%)

PRSP Perspecta
$26.23 /

-0.3 (-1.13%)

06/12/20 William Blair
William Blair sees near-term takeover of Perspecta as unlikely despite Jana news
04/02/20 Wells Fargo
Perspecta price target lowered to $18.50 from $26 at Wells Fargo
03/30/20 William Blair
Perspecta initiated with a Market Perform at William Blair
03/25/20 Wells Fargo
Good news for government contractors in COVID -19 bill, says Wells Fargo
PRSP Perspecta
$26.23 /

-0.3 (-1.13%)

PRSP Perspecta
$26.23 /

-0.3 (-1.13%)

Earnings
Norwood Financial reports Q4 earnings 67c vs. 57c last year » 08:27
01/27/21
01/27
08:27
01/27/21
08:27
NWFL

Norwood Financial

$25.31 /

+0.23 (+0.92%)

Total assets were $1.852B…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NWFL Norwood Financial
$25.31 /

+0.23 (+0.92%)

NWFL Norwood Financial
$25.31 /

+0.23 (+0.92%)

NWFL Norwood Financial
$25.31 /

+0.23 (+0.92%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.